House Panel Turns Up Heat On J&J Over Recalls

Law360, New York (June 3, 2010, 3:28 PM EDT) -- Congressional scrutiny on Johnson & Johnson Services Inc. is increasing, with a U.S. House of Representatives committee launching probes into whether the company conducted “phantom” recalls of Motrin in 2008 and its connection to a recently announced recall of PediaCare made at a J&J plant.

The House Committee on Oversight and Government Reform on Wednesday pressed the pharmaceutical giant's CEO, William C. Weldon, for details on a 2008 “phantom” recall of certain types of Motrin, which the committee first uncovered while reviewing documents turned over by...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.